Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rexall Sundown Cellasene Sales Reach $35 Mil. In Third Quarter

This article was originally published in The Tan Sheet

Executive Summary

Reflecting retailers' initial pipeline purchases, sales of the Cellasene cellulite-reducing dietary supplement were $35 mil. for the fiscal third quarter (ended May 31), an "all-time record" for the company, Rexall Sundown said during a June 15 teleconference. Initial Cellasene sales exceeded the firm's previous record of $32 mil. for Osteo Bi-Flex in the fourth quarter of fiscal 1998.
Advertisement

Related Content

Rexall Sundown Cellasene Claims Cited In FTC Complaint
Rexall Sundown Cellasene Claims Cited In FTC Complaint
Rexall Sundown Cellasene Claims Cited In FTC Complaint
Rexall Osteo-Bi-Flex 27% Sales Growth Paces Strong FY 1999 Results
Rexall Osteo-Bi-Flex 27% Sales Growth Paces Strong FY 1999 Results
Rexall Osteo-Bi-Flex 27% Sales Growth Paces Strong FY 1999 Results

Topics

Advertisement
UsernamePublicRestriction

Register

PS089969

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel